American Century Companies
IMMU

American Century Companies’s Immunomedics Inc IMMU Stock Holding History

American Century Companies’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-900,980
Closed -$76.6M – 2062
2020
Q3 		$76.6M Sell
900,980
-1,863,220
-67% -$94.2M 0.07% 284
2020
Q2 		$98M Buy
2,764,200
+121,973
+5% +$3.57M 0.09% 243
2020
Q1 		$35.6M Sell
2,642,227
-365,715
-12% -$6.15M 0.04% 351
2019
Q4 		$63.6M Sell
3,007,942
-464,496
-13% -$8.19M 0.06% 312
2019
Q3 		$46M Sell
3,472,438
-71,128
-2% -$1.05M 0.05% 351
2019
Q2 		$49.1M Buy
3,543,566
+532,471
+18% +$8.01M 0.05% 367
2019
Q1 		$57.8M Sell
3,011,095
-105,674
-3% -$1.7M 0.06% 333
2018
Q4 		$44.5M Buy
3,116,769
+970,128
+45% +$19.3M 0.05% 359
2018
Q3 		$44.7M Buy
2,146,641
+601,597
+39% +$14.2M 0.04% 365
2018
Q2 		$36.6M Buy
+1,545,044
New +$31.1M 0.04% 406

American Century Companies's IMMU Position: Q4 2020 in Review

American Century Companies sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 900,980 shares — an estimated $76.6M sold.

American Century Companies first reported a position in IMMU in Q2 2018 and held it in 10 quarters. The position peaked at $98M in Q2 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • American Century Companies reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • American Century Companies sold 900,980 Immunomedics Inc shares in Q4 2020, an estimated $76.6M.
  • American Century Companies first reported a position in Immunomedics Inc in Q2 2018 and held it in 10 quarters.
  • American Century Companies's Immunomedics Inc position peaked at $98M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on American Century Companies's 13F filing for Q4 2020, filed 12 Feb 2021.